Literature DB >> 15812664

Acute hypereosinophilia associated with right ventricular thrombosis.

Rahul Roy1, Edmund Ladusans, Russell Keenan.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15812664     DOI： 10.1007/s00431-005-1658-3

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  8 in total

1.  Clinical and echocardiographic features of hypereosinophilic syndromes.

Authors:  S R Ommen; J B Seward; A J Tajik
Journal:  Am J Cardiol       Date:  2000-07-01       Impact factor: 2.778

Review 2.  Eosinophilic leukemoid reaction. Report of a case, its relationship to eosinophilic leukemia, and review of the pediatric literature.

Authors:  F R Rickles; D R Miller
Journal:  J Pediatr       Date:  1972-03       Impact factor: 4.406

3.  The hypereosinophilic syndromes.

Authors:  W R Hardy; R E Anderson
Journal:  Ann Intern Med       Date:  1968-06       Impact factor: 25.391

Review 4.  The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.

Authors:  M J Chusid; D C Dale; B C West; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1975-01       Impact factor: 1.889

Review 5.  The idiopathic hypereosinophilic syndrome.

Authors:  P F Weller; G J Bubley
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

6.  The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature.

Authors:  J E Parrillo; J S Borer; W L Henry; S M Wolff; A S Fauci
Journal:  Am J Med       Date:  1979-10       Impact factor: 4.965

7.  Therapy of the hypereosinophilic syndrome.

Authors:  J E Parrillo; A S Fauci; S M Wolff
Journal:  Ann Intern Med       Date:  1978-08       Impact factor: 25.391

8.  Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders.

Authors:  Animesh Pardanani; Terra Reeder; Luis F Porrata; Chin-Yang Li; Henry D Tazelaar; E Joanna Baxter; Thomas E Witzig; Nicholas C P Cross; Ayalew Tefferi
Journal:  Blood       Date:  2002-12-27       Impact factor: 22.113
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.